Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
94.70
-2.34 (-2.41%)
At close: Oct 6, 2026, 4:00 PM EDT
94.70
0.00 (0.00%)
After-hours: Oct 6, 2026, 8:00 PM EDT
PBE Holdings Information
PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Natera stock at 6.31%, Illumina at 6.29%, Biogen at 5.16%, Gilead Sciences at 5.04%, and Royalty Pharma at 4.77%.
Total Holdings
33
Top 10 Percentage
48.11%
Asset Class
Equity
ETF Category
Health
Assets
422.88M
PE Ratio
23.51
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 6.31% |
| 2 | ILMN | Illumina, Inc. | 6.29% |
| 3 | BIIB | Biogen Inc. | 5.16% |
| 4 | GILD | Gilead Sciences, Inc. | 5.04% |
| 5 | RPRX | Royalty Pharma plc | 4.77% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.73% |
| 7 | AMGN | Amgen Inc. | 4.72% |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | 4.57% |
| 9 | MRNA | Moderna, Inc. | 3.38% |
| 10 | NVAX | Novavax, Inc. | 3.13% |
| 11 | UTHR | United Therapeutics Corporation | 2.95% |
| 12 | VCYT | Veracyte, Inc. | 2.94% |
| 13 | EXEL | Exelixis, Inc. | 2.91% |
| 14 | QGEN | Qiagen N.V. | 2.90% |
| 15 | HALO | Halozyme Therapeutics, Inc. | 2.84% |
| 16 | RGEN | Repligen Corporation | 2.83% |
| 17 | TGTX | TG Therapeutics, Inc. | 2.77% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 2.64% |
| 19 | PTGX | Protagonist Therapeutics, Inc. | 2.63% |
| 20 | VCEL | Vericel Corporation | 2.63% |
| 21 | SRPT | Sarepta Therapeutics, Inc. | 2.61% |
| 22 | INCY | Incyte Corporation | 2.51% |
| 23 | ARDX | Ardelyx, Inc. | 2.50% |
| 24 | LEGN | Legend Biotech Corporation | 2.46% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 2.44% |
As of Oct 5, 2026